(BPT) - Bringing a child into the world can be among life's most joyous and exciting events. But for the parents of very low birth weight (VLBW) preterm babies, the magic of childbirth can be clouded by questions, anxiety, and despair.

Every year, one in 10 babies are born early, facing significant health risks compared to full-term infants. For the smallest preemies - those born weighing less than 1250 grams (2.75 pounds) - the journey can be fraught with challenges. Weeks or months in the neonatal intensive care unit (NICU), serious and costly medical complications, and long-term developmental challenges are not uncommon. One factor has proven vital: the nutrition fed to these preemies while in the NICU.

Nutritional Concerns with Cow Milk-Based Formulas & Fortifiers

Preemie parents wrestle with an array of questions about how best to help their tiny baby grow stronger. This uncertainty has been compounded recently by serious questions surrounding nutritional safety for preterm infants in the NICU.

Since 2022, nearly 1,000 lawsuits have been filed nationwide by preemie parents, related to the use of cow milk-based formulas and fortifiers for their premature infants. The suits allege parents were not warned about known risks the smallest preemies face for developing a potentially fatal intestinal disease, necrotizing enterocolitis (NEC), when fed cow milk-based products.

Human Milk-Based Nutrition as an Option

The good news is that a well-established and thoroughly tested alternative to cow milk-based products exists for the most at-risk newborns. Fortifiers and formulas made from 100% human milk by Prolacta Bioscience improve outcomes for infants born weighing under 1250g and as early as 22 weeks at birth. In 2024 alone, Prolacta's products have been used in more than 50% of Level III and IV NICUs in the U.S.

Prolacta's products have been evaluated in more than 30 studies, including Huston 2018, which demonstrated human milk-based nutrition can substantially improve growth and development for the smallest preemies while significantly reducing the risk of serious complications, including NEC.

Unfortunately, many preemie parents are never told that an alternative to cow milk-based nutritional products exists. This omission, in part, stems from misperceptions about the costs associated with human milk-based products. However, a 2023 peer-reviewed article found that human milk-based protocols actually save hospitals between $500,000 and $3.4 million annually through fewer complications and shorter lengths of stay.

Getting the Word Out

Raising awareness about the role human milk-based nutrition can play in giving VLBW preemies a foothold in life is essential. If you have a preemie or know someone who does, advocate early and often for 100% human milk-based nutritional products. Ask for Prolacta by name. Tell your friends, family, classmates, and colleagues about why human milk-based nutrition is so important. Through advocacy and education, even the tiniest newborns can be given their best chance to not just survive, but to thrive. To learn more, visit Prolacta.com.